Celiac disease TG2 autoantibodies development: it takes two to tango
Open Access
- 14 April 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 11 (4), 1-3
- https://doi.org/10.1038/s41419-020-2412-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2The Journal of Experimental Medicine, 2019
- Non-Invasive Biomarkers for Celiac DiseaseJournal of Clinical Medicine, 2019
- Defective proteostasis in celiac disease as a new therapeutic targetCell Death & Disease, 2019
- Transglutaminase type 2 in the regulation of proteostasisBiological Chemistry, 2018
- T Cells in Celiac DiseaseThe Journal of Immunology, 2017
- Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and deathCell Death & Disease, 2016
- Clinical features and diagnosis of celiac diseaseGastroenterology, 2005
- Gliadin T Cell Epitope Selection by Tissue Transglutaminase in Celiac DiseasePublished by Elsevier BV ,2002
- The widening spectrum of celiac disease.Published by BMJ ,1999
- Identification of tissue transglutaminase as the autoantigen of celiac diseaseNature Medicine, 1997